Chronobiologically explored effects of Telmisartan

Pavel Prikryl, Germaine Cornélissen, Jiri Neubauer, Pavel Prikryl, Zdenek Karpisek, Yoshihiko Watanabe, Kuniaki Otsuka, Franz Halberg

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Effects of Micardis (Telmisartan), alone or with low-dose aspirin, on blood pressure and other cardiovascular endpoints are examined in 20 patients with MESOR-hypertension in a crossover, double-blind, randomized study consisting of three stages, each lasting 7 days: I-placebo, II-Micardis, and III-Micardis with low-dose aspirin. Treatment was administered each day at a different circadian stage, upon awakening, and 3, 6, 9, 12, 15 and 18 hr after awakening. During each stage, the following variables were measured at 3-hr intervals during waking: systolic and diastolic blood pressure, heart rate, ejection fraction, intrarenal resistive index, acceleration time, and serum creatinine. Each data series was analyzed by single cosinor. Results were summarized by population-mean least squares spectra. At matched treatment times, the MESOR and circadian amplitude of each variable were compared among the three treatments by paired t-tests. A prominent circadian rhythm characterizes all variables. Micardis was associated not only with a lowering of blood pressure, but also with a reduction of the circadian blood pressure amplitude. The ejection fraction was increased, and the resistive index and acceleration time were decreased, the effect being more pronounced when low-dose aspirin was added to Micardis. Any circadian-stage dependent effect of Micardis, with or without low-dose aspirin, will require monitoring over spans longer than a single day for a given treatment administration time.

Original languageEnglish (US)
Pages (from-to)119-128
Number of pages10
JournalClinical and Experimental Hypertension
Volume27
Issue number2-3
DOIs
StatePublished - Feb 2005

Bibliographical note

Funding Information:
Keywords blood pressure, chronodiagnosis, chronotherapy, circadian hyper-amplitude-tension (CHAT), ejection fraction, heart rate, low-dose aspirin, Micardis (Telmisartan) #Support for this work comes from the U.S. Public Health Service (GM-13981; FH), Dr. h.c. Earl E. Bakken Fund (GC, FH), and University of Minnesota Supercomputing Institute (GC, FH).

Keywords

  • Blood pressure
  • Chronodiagnosis
  • Chronotherapy
  • Circadian hyper-amplitude- tension (CHAT)
  • Ejection fraction
  • Heart rate
  • Low-dose aspirin
  • Micardis (Telmisartan)

Fingerprint Dive into the research topics of 'Chronobiologically explored effects of Telmisartan'. Together they form a unique fingerprint.

Cite this